3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
2
Phase 2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
7
Gastrointestinal
7
Endocrine
7
Sarcoma
2
Lymphoid
1
CNS
1
Conditions
Glioblastoma
527
Brain Neoplasms
414
Glioma
342
Astrocytoma
239
Central Nervous System Neoplasms
201
Neuroblastoma
195
Gliosarcoma
163
Oligodendroglioma
149
Medulloblastoma
118
Neoplasms
113
Ependymoma
72
Recurrence
70
Breast Neoplasms
69
Sarcoma
65
Melanoma
62
Carcinoma, Non-Small-Cell Lung
58
Osteosarcoma
57
Diffuse Intrinsic Pontine Glioma
48
Wilms Tumor
47
Familial ependymoma
47
Lymphoma
46
Neoplasm Metastasis
45
Optic Nerve Glioma
44
Rhabdomyosarcoma
42
Rhabdoid Tumor
42
Lung Neoplasms
42
Choroid Plexus Neoplasms
42
Neuroectodermal Tumors, Primitive
38
Meningeal Carcinomatosis
38
Ovarian Neoplasms
37
Interventions
amino-acid, glucose, and electrolyte solution
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Gastro-enteropancreatic neuroendocrine tumor
×
CNS
×
Clear all
NCT06441331
2026-05-01
KinLET
ITM Solucin GmbH
Phase 1
Recruiting
20 enrolled